Top Markets
#1 Islamic Coin Islamic Coin +151.47%
#2 DOVU DOVU +49.90%
#3 Velvet Velvet +37.98%
#4 DoubleZero DoubleZero +13.36%
#5 Akedo Akedo +13.09%
#6 HOME HOME +12.74%
#7 Cross Cross +12.16%
#8 Not in Employment, Education, or Training Not in Employment, Education, or Training +11.82%
#9 XPIN Network XPIN Network +9.85%
#10 Fake World Assets Fake World Assets +9.79%
Coin of the day
Islamic Coin Islamic Coin
Settings
Language
ENGLISH
Currency
USD
Theme
Notable Labs, Ltd. Notable Labs, Ltd.

Notable Labs, Ltd.

NTBL
Rank in Stocks #41091
Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company,... Notable Labs, Ltd. operates as a clinical-stage therapeutic platform company, concentrating on creating predictive, personalized treatments for individuals battling cancer. Through its proprietary Predictive Precision Medicines Platform (PPMP), the company virtually tests potential cancer therapies to forecast an individual patient's likely response to a specific drug. The primary goal of the PPMP is to identify and qualify patients who are expected to respond favorably before they even begin treatment, thereby significantly accelerating the clinical development process for these specific patient groups. Notable Labs' current development pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor designed to treat acute myeloid leukemia (AML), pediatric leukemia, and myelodysplastic syndromes. Additionally, it features Fosciclopirox, a prodrug of ciclopirox, also aimed at acute myeloid leukemia. The company's headquarters are located in Foster City, California.
Share Price
$0.0202
Last synced: 2024-11-19
Market Cap
$44.67K
Change (1 day)
-0.49%
Change (1 year)
0.00%
Country
IL
Trade Notable Labs, Ltd. (NTBL)

Category

Healthcare
EPS for Notable Labs, Ltd. (NTBL)
EPS as of June 2024 TTM: $-0.97
According to Notable Labs, Ltd. latest financial reports and stock price the company's current EPS (TTM) is $-0.97. At the end of 2022 the company had a EPS of $-6.50 an increase over its 2021 EPS that were of $-0.22.
EPS history for Notable Labs, Ltd. from 2015 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.97 -80.72%
2023 $-5.03 -22.62%
2022 $-6.50 2,854.55%
2021 $-0.22 -54.17%
2020 $-0.48 26.32%
2019 $-0.38 -38.71%
2018 $-0.62 67.57%
2017 $-0.37 -42.19%
2016 $-0.64 -12.33%
2015 $-0.73 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -1,885.57%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -2,959.79%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -1,512.38%
BE